SureTrader
Interactive Brokers Advertisement
SureTrader
Home > Boards > US OTC > Biotechs > OncoSec Medical Inc. (ONCS)

;)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Vulcan4 Member Profile
 
Followed By 81
Posts 4,000
Boards Moderated 0
Alias Born 10/24/13
160x600 placeholder
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 6/12/2017 4:55:11 PM
OncoSec Announces Technology Access Program Agreement with Jounce Therapeutics, Inc. "PR Newswire (US)" - 6/12/2017 6:01:00 AM
OncoSec Granted Orphan Drug Designation from the U.S. FDA for the Treatment of Unresectable Metastatic Melanoma "PR Newswire (US)" - 6/8/2017 4:30:00 PM
OncoSec to Present at LD Micro Invitational "PR Newswire (US)" - 6/2/2017 6:01:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 6/1/2017 4:18:59 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/1/2017 4:12:06 PM
OncoSec Announces Third Quarter and YTD Results for Fiscal Year 2017 "PR Newswire (US)" - 6/1/2017 4:01:00 PM
OncoSec to Host Third Quarter Financial Conference Call on June 1, 2017 "PR Newswire (US)" - 5/11/2017 6:45:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/11/2017 6:08:41 AM
OncoSec Announces Clinical Collaboration with Merck to Evaluate Combination of ImmunoPulse® IL-12 and KEYTRUDA® (pembrolizu... "PR Newswire (US)" - 5/10/2017 6:00:00 AM
OncoSec to Present at Biomarkers & Immuno-Oncology World Congress 2017 "PR Newswire (US)" - 5/2/2017 8:43:00 AM
Heat Biologics Presents New Preclinical Data from OncoSec Collaboration at the American Association for Cancer Research (AACR... "GlobeNewswire Inc." - 4/5/2017 8:00:00 AM
OncoSec Presents Preclinical Data Demonstrating Improved Systemic Anti-Tumor Response Following Modifications to IL-12 Gene D... "PR Newswire (US)" - 4/3/2017 8:01:00 AM
OncoSec to Present Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2017 "PR Newswire (US)" - 3/28/2017 6:01:00 AM
Innovative Immunotherapies Emerging as the Cancer Treatments of the Future "NetworkNewsWire" - 3/23/2017 8:30:00 AM
OncoSec Medical's Intratumoral Plasmid IL-12 Demonstrates Effectiveness at Enhancing Tumor Immunogenicity in Preclinical Tumo... "PR Newswire (US)" - 3/21/2017 2:01:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 3/16/2017 4:19:03 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/16/2017 4:07:21 PM
OncoSec Announces Second Quarter and YTD Results for Fiscal Year 2017 "PR Newswire (US)" - 3/16/2017 4:01:00 PM
OncoSec to Present at Scientific and Investment Conferences in March "PR Newswire (US)" - 3/7/2017 9:22:00 AM
OncoSec to Host Second Quarter Financial Conference Call on March 16, 2017 "PR Newswire (US)" - 3/2/2017 6:01:00 AM
OncoSec Granted FDA Fast Track Designation for ImmunoPulse® IL-12 for the Treatment of Metastatic Melanoma Following Progres... "PR Newswire (US)" - 2/27/2017 6:01:00 AM
OncoSec Announces Positive Phase II Data Demonstrating Company's ImmunoPulse® IL-12 in Combination with Pembrolizumab Increa... "PR Newswire (US)" - 2/23/2017 11:30:00 AM
OncoSec to Present New Clinical Data from Phase 2 Combination Study at ASCO-SITC Clinical Immuno-Oncology Symposium and Corpo... "PR Newswire (US)" - 2/8/2017 6:01:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/30/2017 4:38:26 PM
Vulcan4   Tuesday, 12/24/13 03:30:05 PM
Re: DDJ post# 6497
Post # of 39532 
;)

I'm wit ya, man.. :)


SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist